Stocks · Technology · Laboratory Analytical Instruments

Avantor, Inc.

AVTR Clue Score37
United States Fiscal year ends December CIK 0001722482 Results filed 28 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Gregory T Lucier
8 May 2026
Director
Buy indirect
10,000
$8.32
$83.20K
Simon Dingemans
1 May 2026
Director
Buy indirect
25,000
$8.14
$203.50K
Sanjeev K Mehra
10 Mar 2026
Director
Buy indirect
125,000
$8.01
$1.00M
Gregory T Lucier
19 Feb 2026
Director
Buy indirect
50,000
$9.16
$458.00K
Gregory L Summe
12 Feb 2026
Director
Buy indirect
100,000
$9.40
$940.00K
Sanjeev K Mehra
5 Dec 2025
Director
Buy indirect
350,000
$11.09
$3.88M
Emmanuel Ligner
17 Nov 2025
President and CEO
Buy
87,500
$11.35
$993.13K
Gregory L Summe
30 Oct 2025
Director
Buy indirect
100,000
$11.25
$1.13M
Gregory L Summe
21 Aug 2025
Director
Buy indirect
100,000
$12.56
$1.26M
Steven W Eck
5 Aug 2025
SVP & Chief Accounting Officer
Sold on a plan
3,476
$11.39
$39.59K
Gregory L Summe
23 May 2025
Director
Buy indirect
30,000
$12.50
$375.00K
Gregory L Summe
22 May 2025
Director
Buy indirect
20,000
$12.65
$253.00K
Gregory L Summe
7 May 2025
Director
Buy indirect
25,000
$12.00
$300.00K
Joseph R Massaro
29 Apr 2025
Director
Buy
8,100
$12.30
$99.63K
Jonathan M Peacock
28 Apr 2025
Director
Buy
8,091
$12.81
$103.65K
Lan Kang
28 Apr 2025
Director
Buy
5,000
$12.57
$62.85K
Gregory L Summe
28 Apr 2025
Director
Buy indirect
25,000
$12.50
$312.50K
Steven W Eck
27 Feb 2025
SVP & Chief Accounting Officer
Sold on a plan
1,033
$17.00
$17.56K
James Bramwell
27 Feb 2025
EVP Sales, Customer Excellence
Sold on a plan
774
$17.00
$13.16K
Steven W Eck
26 Feb 2025
SVP & Chief Accounting Officer
Sold on a plan
4,907
$17.53
$86.02K
James Bramwell
26 Feb 2025
EVP Sales, Customer Excellence
Sold on a plan
3,758
$17.53
$65.88K
Steven W Eck
5 Sep 2024
SVP & Chief Accounting Officer
Sell
3,525
$25.06
$88.34K
Christophe Couturier
31 Jul 2024
EVP, Amea
Sold on a plan
100
$28.00
$2.80K
Christophe Couturier
30 Jul 2024
EVP, Amea
Sold on a plan
10,000
$27.00
$270.00K
Steven W Eck
8 Mar 2024
SVP & Chief Accounting Officer
Sold on a plan
3,685
$25.63
$94.45K
Christophe Couturier
29 Feb 2024
EVP, Amea
Sell
13,074
$24.53
$320.71K
James Bramwell
29 Feb 2024
EVP Sales, Customer Excellence
Sell
4,910
$24.52
$120.39K
James Bramwell
27 Feb 2024
EVP Sales, Customer Excellence
Sell
6,203
$24.49
$151.91K
Steven W Eck
7 Sep 2023
SVP & Chief Accounting Officer
Sell
7,577
$20.64
$156.39K
Frederic Vanderhaegen
25 Aug 2023
EVP, Americas and Europe
Sell
25,000
$21.47
$536.75K
Christophe Couturier
11 Apr 2023
EVP, Amea
Sold on a plan
1,498
$21.18
$31.73K
Gerard Brophy
3 Mar 2023
EVP, Biopharma Production
Sell
3,914
$25.00
$97.85K
Christophe Couturier
28 Feb 2023
EVP, Amea
Sell
2,324
$24.32
$56.52K
Gerard Brophy
27 Feb 2023
EVP, Biopharma Production
Sell
3,059
$25.00
$76.48K
Christophe Couturier
23 Feb 2023
EVP, Amea
Sell
3,078
$24.24
$74.61K
Christophe Couturier
22 Feb 2023
EVP, Amea
Sell
19,160
$24.12
$462.14K
Gerard Brophy
2 Feb 2023
EVP, Biopharma Production
Sell
11,339
$25.06
$284.16K
Michael Stubblefield
16 Nov 2022
CEO
Buy indirect
15,000
$20.95
$314.25K
Thomas A Szlosek
16 Nov 2022
EVP & CFO
Buy indirect
12,500
$20.71
$258.85K
Frederic Vanderhaegen
23 May 2022
EVP, Americas & Europe
Sell
39,000
$31.61
$1.23M
Gerard Brophy
20 May 2022
EVP, Biopharma Production
Sell
19,603
$31.27
$612.99K
Gerard Brophy
1 Mar 2022
EVP, Biopharma Production
Sell
2,027
$34.47
$69.87K
Gerard Brophy
23 Feb 2022
EVP, Biopharma Production
Sell
3,059
$33.79
$103.36K
Gerard Brophy
5 Jan 2022
EVP, Biopharma Production
Sell
11,551
$38.65
$446.45K
Gerard Brophy
3 Jan 2022
EVP, Biopharma Production
Sold after exercise
59,418
$40.77
$2.42M
Christophe Couturier
27 Dec 2021
EVP, Amea
Sold after exercise
10,184
$41.63
$423.96K
Christophe Couturier
22 Dec 2021
EVP, Amea
Sold after exercise
28,125
$41.53
$1.17M
Christophe Couturier
21 Dec 2021
EVP, Amea
Sold after exercise
38,309
$41.00
$1.57M
Christophe Couturier
9 Dec 2021
EVP, Amea
Sold after exercise
7,859
$40.24
$316.25K
Christophe Couturier
8 Dec 2021
EVP, Amea
Sold after exercise
5,828
$40.00
$233.12K
Rajiv Gupta
1 Dec 2021
Director
Sell
100,000
$39.30
$3.93M
Frederic Vanderhaegen
12 Nov 2021
EVP, Europe
Sold after exercise
80,000
$38.25
$3.06M
Frederic Vanderhaegen
11 Nov 2021
EVP, Europe
Sell
60,804
$38.41
$2.34M
Rajiv Gupta
1 Nov 2021
Director
Sell
100,000
$40.31
$4.03M
Rajiv Gupta
1 Oct 2021
Director
Sell
100,000
$39.94
$3.99M
Michael Stubblefield
20 Sep 2021
President and CEO
Sell
141,300
$42.37
$5.99M
Rajiv Gupta
1 Sep 2021
Director
Sell
100,000
$39.45
$3.95M
Steven W Eck
26 Aug 2021
SVP & Chief Accounting Officer
Sell
17,383
$40.08
$696.71K
Rajiv Gupta
20 Aug 2021
Director
Sell
100,000
$38.81
$3.88M
Gerard Brophy
30 Jul 2021
EVP, Biopharma Production
Sold after exercise
81,125
$37.24
$3.02M
James Bramwell
20 Jul 2021
EVP, Strategic Partners
Sell
6,112
$37.00
$226.14K
Jo Natauri
12 Jul 2021
Director
Buy indirect
300
$36.33
$10.90K
James Bramwell
9 Jul 2021
EVP, Strategic Partners
Sell
12,221
$35.64
$435.56K
James Bramwell
9 Jul 2021
EVP, Strategic Partners
Sell
6,110
$35.56
$217.27K
Christophe Couturier
28 Jun 2021
EVP, Amea
Sell
28,096
$35.73
$1.00M
Rajiv Gupta
25 Jun 2021
Director
Sell
68,605
$35.32
$2.42M
Michael Stubblefield
10 Jun 2021
President and CEO
Sold after exercise
57,375
$32.48
$1.86M
Michael Stubblefield
10 Jun 2021
President and CEO
Sold after exercise
42,512
$32.48
$1.38M
Michael Stubblefield
9 Jun 2021
President and CEO
Sold after exercise
235,170
$32.03
$7.53M
Michael Stubblefield
8 Jun 2021
President and CEO
Sold after exercise
152,643
$32.04
$4.89M
Devashish Ohri
27 May 2021
EVP, Imea
Sold after exercise
100,000
$31.99
$3.20M
Rajiv Gupta
27 May 2021
Director
Sell indirect
78,109
$31.94
$2.49M
Devashish Ohri
26 May 2021
EVP, Imea
Sold after exercise
15,000
$31.87
$478.05K
Rajiv Gupta
26 May 2021
Director
Sell indirect
150,000
$31.89
$4.78M
Devashish Ohri
24 May 2021
EVP, Imea
Sold after exercise
9,124
$31.75
$289.69K
Rajiv Gupta
24 May 2021
Director
Sell indirect
157,571
$31.57
$4.97M
Rajiv Gupta
24 May 2021
Director
Sell indirect
180,000
$31.74
$5.71M
Michael Wondrasch
21 May 2021
EVP & CIO
Sell
18,488
$31.41
$580.71K
Gerard Brophy
20 May 2021
EVP, Biopharma Production
Sell
19,603
$31.10
$609.65K
Christophe Couturier
20 May 2021
EVP, Amea
Sell
25,010
$31.13
$778.56K
Justin Miller
20 May 2021
EVP & General Counsel
Sell
18,488
$31.12
$575.35K
Devashish Ohri
14 May 2021
EVP, Imea
Exercised, kept
25,000
$23.21
$580.25K
Jo Natauri
11 May 2021
Director
Sell indirect
2,626,771
$30.68
$80.59M
Devashish Ohri
30 Apr 2021
EVP, Imea
Sold after exercise
53,649
$32.58
$1.75M
Justin Miller
12 Apr 2021
EVP & General Counsel
Sold after exercise
100,000
$33.21
$3.32M
Justin Miller
12 Apr 2021
EVP & General Counsel
Sold after exercise
2,895
$31.75
$91.92K
James Bramwell
12 Apr 2021
EVP, Strategic Partners
Sell
2,505
$32.00
$80.16K
Frederic Vanderhaegen
12 Apr 2021
EVP, Europe
Sell
17,075
$31.83
$543.50K
Frederic Vanderhaegen
12 Apr 2021
EVP, Europe
Sell
10,000
$31.75
$317.50K
Devashish Ohri
12 Apr 2021
EVP, Imea
Sold after exercise
100,160
$32.37
$3.24M
Frederic Vanderhaegen
9 Mar 2021
EVP, Europe
Sell
10,000
$28.21
$282.10K
Michael Wondrasch
2 Mar 2021
EVP & CIO
Sell
3,036
$28.71
$87.16K
Gerard Brophy
24 Feb 2021
EVP, Biopharma Production
Sell
3,059
$27.93
$85.44K
Gerard Brophy
22 Feb 2021
EVP, Biopharma Production
Sold after exercise
19,769
$28.62
$565.79K
Michael Wondrasch
5 Feb 2021
EVP & CIO
Sold after exercise
40,000
$29.77
$1.19M
Michael Wondrasch
5 Feb 2021
EVP & CIO
Sold after exercise
9,468
$29.77
$281.86K
Gerard Brophy
11 Jan 2021
EVP, Biopharma Production
Sold after exercise
162,248
$30.04
$4.87M
Gerard Brophy
11 Jan 2021
EVP, Biopharma Production
Sold after exercise
216,332
$30.08
$6.51M
James Bramwell
11 Jan 2021
EVP, Strategic Partners
Sell
2,505
$30.00
$75.15K
Gerard Brophy
6 Jan 2021
EVP, Biopharma Production
Sell
11,509
$27.24
$313.51K
Gerard Brophy
4 Jan 2021
EVP, Biopharma Production
Sold after exercise
59,418
$27.84
$1.65M
James Bramwell
21 Dec 2020
EVP, Strategic Partners
Sell
10,020
$27.14
$271.94K
Christi Shaw
11 Dec 2020
Director
Sell
14,286
$26.68
$381.15K
Michael Stubblefield
7 Dec 2020
President and CEO
Sold after exercise
98,452
$27.45
$2.70M
Michael Stubblefield
4 Dec 2020
President and CEO
Sold after exercise
412,188
$27.08
$11.16M
New Mountain Investments III, LLC
10 Nov 2020
10% owner
Sell indirect
36,016,093
$24.81
$893.49M
Devashish Ohri
5 Oct 2020
EVP, Imea
Sold after exercise
50,000
$23.34
$1.17M
Devashish Ohri
5 Oct 2020
EVP, Imea
Sold after exercise
35,000
$23.47
$821.45K
Devashish Ohri
5 Oct 2020
EVP, Imea
Sold after exercise
18,440
$23.53
$433.89K
Devashish Ohri
16 Sep 2020
EVP, Imea
Sold after exercise
35,000
$23.02
$805.70K
Justin Miller
8 Sep 2020
EVP & General Counsel
Sell
22,887
$21.17
$484.52K
New Mountain Investments III, LLC
21 Aug 2020
10% owner
Sell indirect
25,575,472
$19.51
$498.89M
Goldman Sachs & Co. LLC
21 Aug 2020
10% owner
Sell indirect
15,397,005
$19.51
$300.34M
Jo Natauri
21 Aug 2020
Director
Sell indirect
15,397,005
$19.51
$300.34M
Rajiv Gupta
19 Aug 2020
Director
Exercised, kept
1,147,970
$1.60
$1.84M
Devashish Ohri
30 Jul 2020
EVP, Imea
Sold after exercise
35,000
$21.37
$747.95K
Devashish Ohri
29 May 2020
EVP, Imea
Sold after exercise
35,000
$19.07
$667.45K
Devashish Ohri
29 May 2020
EVP, Imea
Sold after exercise
30,000
$18.57
$557.10K
Goldman Sachs & Co. LLC
26 May 2020
10% owner
Sell indirect
13,726,411
$15.90
$218.25M
Thomas Connolly
26 May 2020
Director
Sell indirect
13,726,411
$15.90
$218.25M
Jo Natauri
26 May 2020
Director
Sell indirect
13,726,411
$15.90
$218.25M
New Mountain Investments III, LLC
26 May 2020
10% owner
Sell indirect
20,886,424
$15.90
$332.19M
Michael Wondrasch
22 May 2020
EVP & CIO
Sell
22,987
$17.82
$409.63K
Gerard Brophy
20 May 2020
EVP, Biopharma Production
Sell
25,495
$17.36
$442.59K
Michael Stubblefield
12 Mar 2020
CEO
Exercised, kept
200,000
$1.60
$320.00K
Rajiv Gupta
10 Mar 2020
Director
Exercised, kept
143,000
$1.60
$228.80K
Devashish Ohri
18 Feb 2020
EVP, Imea
Sold after exercise
20,000
$17.54
$350.80K
Thomas Connolly
25 Sep 2019
Director
Sell indirect
9,922
$14.80
$146.85K
Thomas Connolly
25 Sep 2019
Director
Buy indirect
9,922
$14.80
$146.85K
Thomas Connolly
25 Sep 2019
Director
Sell indirect
5,164
$14.79
$76.38K
Thomas Connolly
25 Sep 2019
Director
Buy indirect
5,164
$14.79
$76.38K
Thomas Connolly
25 Sep 2019
Director
Sell indirect
100
$14.79
$1.48K
Thomas Connolly
25 Sep 2019
Director
Buy indirect
100
$14.79
$1.48K
Thomas Connolly
25 Sep 2019
Director
Sell indirect
3,800
$14.78
$56.16K
Thomas Connolly
25 Sep 2019
Director
Buy indirect
3,800
$14.78
$56.16K
Thomas Connolly
25 Sep 2019
Director
Sell indirect
100
$14.78
$1.48K
Thomas Connolly
25 Sep 2019
Director
Buy indirect
100
$14.78
$1.48K
Thomas Connolly
25 Sep 2019
Director
Sell indirect
4,146
$14.76
$61.19K
Thomas Connolly
25 Sep 2019
Director
Buy indirect
4,146
$14.76
$61.19K
Thomas Connolly
25 Sep 2019
Director
Sell indirect
1,768
$14.70
$25.99K
Thomas Connolly
25 Sep 2019
Director
Buy indirect
1,768
$14.70
$25.99K
Goldman Sachs & Co. LLC
25 Sep 2019
10% owner
Sell indirect
9,922
$14.80
$146.85K
Goldman Sachs & Co. LLC
25 Sep 2019
10% owner
Buy indirect
9,922
$14.80
$146.85K
Goldman Sachs & Co. LLC
25 Sep 2019
10% owner
Sell indirect
5,164
$14.79
$76.38K
Goldman Sachs & Co. LLC
25 Sep 2019
10% owner
Buy indirect
5,164
$14.79
$76.38K
Goldman Sachs & Co. LLC
25 Sep 2019
10% owner
Sell indirect
100
$14.79
$1.48K
Goldman Sachs & Co. LLC
25 Sep 2019
10% owner
Buy indirect
100
$14.79
$1.48K
Goldman Sachs & Co. LLC
25 Sep 2019
10% owner
Sell indirect
3,800
$14.78
$56.16K
Goldman Sachs & Co. LLC
25 Sep 2019
10% owner
Buy indirect
3,800
$14.78
$56.16K
Goldman Sachs & Co. LLC
25 Sep 2019
10% owner
Sell indirect
100
$14.78
$1.48K
Goldman Sachs & Co. LLC
25 Sep 2019
10% owner
Buy indirect
100
$14.78
$1.48K
Goldman Sachs & Co. LLC
25 Sep 2019
10% owner
Sell indirect
4,146
$14.76
$61.19K
Goldman Sachs & Co. LLC
25 Sep 2019
10% owner
Buy indirect
4,146
$14.76
$61.19K
Goldman Sachs & Co. LLC
25 Sep 2019
10% owner
Sell indirect
1,768
$14.70
$25.99K
Goldman Sachs & Co. LLC
25 Sep 2019
10% owner
Buy indirect
1,768
$14.70
$25.99K
Jo Natauri
25 Sep 2019
Director
Sell indirect
9,922
$14.80
$146.85K
Jo Natauri
25 Sep 2019
Director
Buy indirect
9,922
$14.80
$146.85K
Jo Natauri
25 Sep 2019
Director
Sell indirect
5,164
$14.79
$76.38K
Jo Natauri
25 Sep 2019
Director
Buy indirect
5,164
$14.79
$76.38K
Jo Natauri
25 Sep 2019
Director
Sell indirect
100
$14.79
$1.48K
Jo Natauri
25 Sep 2019
Director
Buy indirect
100
$14.79
$1.48K
Jo Natauri
25 Sep 2019
Director
Sell indirect
3,800
$14.78
$56.16K
Jo Natauri
25 Sep 2019
Director
Buy indirect
3,800
$14.78
$56.16K
Jo Natauri
25 Sep 2019
Director
Sell indirect
100
$14.78
$1.48K
Jo Natauri
25 Sep 2019
Director
Buy indirect
100
$14.78
$1.48K
Jo Natauri
25 Sep 2019
Director
Sell indirect
4,146
$14.76
$61.19K
Jo Natauri
25 Sep 2019
Director
Buy indirect
4,146
$14.76
$61.19K
Jo Natauri
25 Sep 2019
Director
Sell indirect
1,768
$14.70
$25.99K
Jo Natauri
25 Sep 2019
Director
Buy indirect
1,768
$14.70
$25.99K
Thomas Connolly
9 Sep 2019
Director
Sell indirect
149,694
$16.46
$2.46M
Thomas Connolly
9 Sep 2019
Director
Buy indirect
149,694
$16.46
$2.46M
Goldman Sachs & Co. LLC
9 Sep 2019
10% owner
Sell indirect
149,694
$16.46
$2.46M
Goldman Sachs & Co. LLC
9 Sep 2019
10% owner
Buy indirect
149,694
$16.46
$2.46M
Jo Natauri
9 Sep 2019
Director
Sell indirect
149,694
$16.46
$2.46M
Jo Natauri
9 Sep 2019
Director
Buy indirect
149,694
$16.46
$2.46M
Thomas Connolly
6 Sep 2019
Director
Sell indirect
49,200
$17.06
$839.54K
Thomas Connolly
6 Sep 2019
Director
Buy indirect
49,200
$17.06
$839.54K
Thomas Connolly
6 Sep 2019
Director
Sell indirect
67,437
$16.51
$1.11M
Thomas Connolly
6 Sep 2019
Director
Buy indirect
67,437
$16.51
$1.11M
Goldman Sachs & Co. LLC
6 Sep 2019
10% owner
Sell indirect
49,200
$17.06
$839.54K
Goldman Sachs & Co. LLC
6 Sep 2019
10% owner
Buy indirect
49,200
$17.06
$839.54K
Goldman Sachs & Co. LLC
6 Sep 2019
10% owner
Sell indirect
67,437
$16.51
$1.11M
Goldman Sachs & Co. LLC
6 Sep 2019
10% owner
Buy indirect
67,437
$16.51
$1.11M
Jo Natauri
6 Sep 2019
Director
Sell indirect
49,200
$17.06
$839.54K
Jo Natauri
6 Sep 2019
Director
Buy indirect
49,200
$17.06
$839.54K
Jo Natauri
6 Sep 2019
Director
Sell indirect
67,437
$16.51
$1.11M
Jo Natauri
6 Sep 2019
Director
Buy indirect
67,437
$16.51
$1.11M
Thomas Connolly
12 Aug 2019
Director
Sell indirect
9
$16.66
$149.94
Thomas Connolly
12 Aug 2019
Director
Buy indirect
9
$16.66
$149.94
Thomas Connolly
12 Aug 2019
Director
Sell indirect
16,245
$16.51
$268.26K
Thomas Connolly
12 Aug 2019
Director
Buy indirect
16,245
$16.51
$268.26K
Goldman Sachs & Co. LLC
12 Aug 2019
10% owner
Sell indirect
9
$16.66
$149.94
Goldman Sachs & Co. LLC
12 Aug 2019
10% owner
Buy indirect
9
$16.66
$149.94
Goldman Sachs & Co. LLC
12 Aug 2019
10% owner
Sell indirect
16,245
$16.51
$268.26K
Goldman Sachs & Co. LLC
12 Aug 2019
10% owner
Buy indirect
16,245
$16.51
$268.26K
Jo Natauri
12 Aug 2019
Director
Sell indirect
9
$16.66
$149.94
Jo Natauri
12 Aug 2019
Director
Buy indirect
9
$16.66
$149.94
Jo Natauri
12 Aug 2019
Director
Sell indirect
16,245
$16.51
$268.26K
Jo Natauri
12 Aug 2019
Director
Buy indirect
16,245
$16.51
$268.26K
Thomas Connolly
6 Aug 2019
Director
Sell indirect
88
$16.66
$1.47K
Thomas Connolly
6 Aug 2019
Director
Buy indirect
88
$16.66
$1.47K
Goldman Sachs & Co. LLC
6 Aug 2019
10% owner
Sell indirect
88
$16.66
$1.47K
Goldman Sachs & Co. LLC
6 Aug 2019
10% owner
Buy indirect
88
$16.66
$1.47K
Jo Natauri
6 Aug 2019
Director
Sell indirect
88
$16.66
$1.47K
Jo Natauri
6 Aug 2019
Director
Buy indirect
88
$16.66
$1.47K
Thomas Connolly
31 Jul 2019
Director
Sell indirect
55
$17.55
$965.12
Thomas Connolly
31 Jul 2019
Director
Buy indirect
55
$17.55
$965.12
Goldman Sachs & Co. LLC
31 Jul 2019
10% owner
Sell indirect
55
$17.55
$965.12
Goldman Sachs & Co. LLC
31 Jul 2019
10% owner
Buy indirect
55
$17.55
$965.12
Jo Natauri
31 Jul 2019
Director
Sell indirect
55
$17.55
$965.12
Jo Natauri
31 Jul 2019
Director
Buy indirect
55
$17.55
$965.12
Goldman Sachs & Co. LLC
13 Jun 2019
10% owner
Exercised, kept indirect
1,133,920
$0.00
$2.27K
Thomas Connolly
13 Jun 2019
Director
Exercised, kept indirect
1,133,920
$0.00
$2.27K
Jo Natauri
13 Jun 2019
Director
Exercised, kept indirect
1,133,920
$0.00
$2.27K
New Mountain Investments III, LLC
21 May 2019
10% owner
Sell indirect
100
$14.00
$1.40K
Thomas Connolly
17 May 2019
Director
Sell indirect
14,049
$14.00
$196.69K
Thomas Connolly
17 May 2019
Director
Buy indirect
13,099
$14.00
$183.39K
Goldman Sachs & Co. LLC
17 May 2019
10% owner
Sell indirect
14,049
$14.00
$196.69K
Goldman Sachs & Co. LLC
17 May 2019
10% owner
Buy indirect
13,099
$14.00
$183.39K
Jo Natauri
17 May 2019
Director
Sell indirect
14,049
$14.00
$196.69K
Jo Natauri
17 May 2019
Director
Buy indirect
13,099
$14.00
$183.39K

What was left out

Form 4 filings counted 437
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 35
Sales at will 106
Transactions with no price 0
Shares from compensation/vesting 259,396,189
Sales filed before the plan box existed 100
History held since 23 May 2019